Sort
85,873 grants matching “alzheimers”
The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE)
$1,654,296Susan Cheng · Cedars-Sinai Medical Center · U54 · FY2022 · AG
Supplement to Cognitive training to reduce incidence of cognitive impairment in older adults
$1,654,007Jerri Edwards · University Of South Florida · R01 · FY2022 · AG
PME-1: Pathogenetic Role and Therapeutic Opportunity in Neurodegenerative Mixed Proteinopathies
$1,653,093M. Maral Mouradian · Rutgers Biomedical And Health Sciences · RF1 · FY2023 · NS
Aging of Emotion Circuitry and Risk for Alzheimer's disease: Impact of Sex, Immunity, and Fetal Origins
$1,652,891Jill M Goldstein · Massachusetts General Hospital · R01 · FY2025 · AG
EINSTEIN AGING STUDY
$1,652,762Yeshiva University · P01 · FY2001 · AG
Aging and Dementia in Adults with Down Syndrome
$1,652,491Wayne P Silverman · Hugo W. Moser Res Inst Kennedy Krieger · P01 · FY2014 · HD
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease
$1,652,369Mone Zaidi · Icahn School Of Medicine At Mount Sinai · U01 · FY2024 · AG
Lambda Genetic Networks and Lambda Red-Mediated Recombination
$1,652,241Donald Court · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study of India (LASI)-Genomic study.
$1,652,049Jinkook Lee · University Of Southern California · U01 · FY2022 · AG
Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study of India (LASI)-Genomic study.
$1,652,049Jinkook Lee · University Of Southern California · U01 · FY2023 · AG
EARLY MARKERS OF ALZHEIMER'S DISEASE IN THE BLSA
$1,651,887Nicole Leonard · Johns Hopkins University · N01 · FY2009 · AG
PHASE II/III trial for Slowing Progression in Mild Cognitive Impairment
$1,651,734Michela Gallagher · Johns Hopkins University · R01 · FY2015 · AG
PRESENILIN BIOLOGY &THE MECHANISM OF ALZHEIMERS DISEASE
$1,651,429Brigham And Women'S Hospital · P01 · FY2002 · AG
Alpha-Synuclein aberrantly modifies the nanoscale distribution and function of ion channels to promote neuronal cytotoxicity
$1,650,534Eamonn James Dickson · University Of California At Davis · RF1 · FY2023 · NS
NBB BRAIN BANK
$1,649,674David Lewis · University Of Pittsburgh At Pittsburgh · N01 · FY2024 · DA
Actions of Nuclear Receptors on TREM2+ myeloid cells and microglia in AD brain
$1,649,492Gary E. Landreth · Indiana University Indianapolis · RF1 · FY2016 · AG
Aging Well, Sleeping Efficiently: Intervention Studies
$1,649,021University Of Pittsburgh At Pittsburgh · P01 · FY2004 · AG
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets
$1,648,575Philip L De Jager · Columbia University Health Sciences · U01 · FY2019 · AG
Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease
$1,648,310John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Multidomain Alzheimers Risk Reduction Study (MARRS) Pilot
$1,647,910Kristine Yaffe · University Of California, San Francisco · R01 · FY2021 · AG
Development of an ophthalmic diagnostic probe for neurodegenerativedisorders
$1,647,908Stella Sarraf · Amydis Diagnostics, Inc. · R44 · FY2016 · AG
EFFECTS OF DOCOSAHEXAENOIC ACID (DHA) IN SLOWING THE PROGRESSION OF AD (DHA)
$1,647,782Joseph F Quinn · University Of California, San Diego · U01 · FY2008 · AG
INFORMATICS CORE
$1,647,744Paul S. Aisen · University Of California, San Diego · U19 · FY2019 · AG
CLEC7A in microglia biology and Alzheimer's disease
$1,647,138John R Lukens · University Of Virginia · RF1 · FY2023 · AG
Imaging and Analysis Techniques to Construct a Cell Census Atlas of the Human Brain
$1,646,759Bruce Fischl · Massachusetts General Hospital · U01 · FY2018 · MH